Ancora Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Ancora Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,000	Closed	-$229K	–	722
2017 Q4	$229K	Hold	5,000	–	–	0.01%	565
2017 Q3	$224K	Buy	+5,000	New	+$170K	0.01%	599

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Ancora Advisors's JUNO Position: Q1 2018 in Review

Ancora Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 5,000 shares — an estimated $229K sold.

Ancora Advisors first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $229K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Ancora Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Ancora Advisors sold 5,000 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $229K.
Ancora Advisors first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
Ancora Advisors's Juno Therapeutics, Inc. position peaked at $229K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Ancora Advisors's 13F filing for Q1 2018, filed 15 May 2018.